Healthy.io Brings Smartphone Urine Tests to U.S. Homes

The Israel-based startup partnered with the American National Kidney Foundation and Pennsylvania-based Geisinger Health System to offer its testing kits to U.S. patients Lilach Baumer | 19:26 15.04.18 The American National Kidney Foundation and Pennsylvania-based Geisinger Health System have partnered with Israel-based startup Healthy.io to enable smartphone-based urine tests at home. On Monday, the three will launch […]

Mylan buys rights to Israel-developed Multiple Sclerosis treatment

MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week By TOI STAFF 11 April 2018, 12:19 am | Times New Israel Mylan already sells a generic version of Teva Pharmaceuticals’ widely-used MS treatment, Copaxone. But, if GA Depot successfully completes its Phase III clinical trials, it will be formidable competition to […]

Medtronic Buys Medical Visualization Company Visionsense for $65 Million

The medical device developer intends to integrate Israel-based Visionsense’s operations into its own activities Meir Orbach | 10:16 10.04.18 | Calcalistech Medical device maker Medtronic PLC is buying Israel-based medical visualization company Visionsense Ltd. for $65 million, two people familiar with the matter told Calcalist on condition of anonymity. Visionsense will receive an upfront payment of $40 […]

Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing

  EMERGING ISRAELI BIOPHARMA FLIES FLAG FOR EX-BMS CANCER THERAPY by Phil Taylor | Apr 10, 2018 9:57am | FierceBiotech Israeli biotech Ayala Pharmaceuticals, founded last year as a development vehicle for two of Bristol-Myers Squibb’s cancer candidates, has raised $17 million in a series A financing. The new company licensed rights to BMS’s gamma secretase inhibitor BMS-906024 in December, […]

Israel On Quest For Digital Health Domination

  10 Apr 2018 | MEDTECH NEWS by Catherine Longworth Israel has set its sights on becoming a global leader in digital health, boosted by the government’s new five-year plan to invest nearly $300m to drive innovation in this space.   Israel is on a mission. The self-dubbed “Start-Up Nation” has proclaimed its ambition to become the […]

New VC fund to set sights on Israeli tech for eye diseases

Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can become a ‘meaningful player’ in vision-related developments By SHOSHANNA SOLOMON| April 2018, 12:31 pm | Times of Israel Dr. Barak Azmon, an ophthalmologist and serial entrepreneur, is convinced Israel can become a “meaningful player” in technologies relating to eyesight. He and his partners are […]

MIXiii-Biomed 2018 – Registration and program online

MIXiii-Biomed 2018 – Registration and program online MIXiii-Biomed 2018 is fast approaching. This prestigious conference and exhibition is once again ready to launch start-ups into the international arena and to help thousands of delegates connect and establish strong networking possibilities. REGISTER NOW Use this opportunity to participate and become a key player in the Biomed […]

MIXiii-BIOMED 2018: Introducing the Best of Israel’s Life Science Innovations

Israel’s 17th national life science and technology week to be held on May 15-17, 2018 at the David InterContinental Hotel in Tel Aviv NEWS PROVIDED BY MIXiii-BIOMED 07:30 ET | TEL AVIV, Israel, April 3, 2018 /PRNewswire/   The 17th annual MIXiii-BIOMED 2018, the premier international life science conference in Israel, will take place between May 15-17, 2018, at the David InterContinental Hotel in Tel […]

MedImmune to Develop Compugen Immuno-Oncology Antibodies

April 2, 2018 | GEN News Highlights AstraZeneca’s #MedImmune subsidiary has agreed to exclusively license and develop #bispecific and multispecific #immuno-oncology antibody products from Compugen’s pipeline, through a collaboration that #Compugen said today could generate for it up to $210 million-plus.   Compugen said it will grant MedImmune an exclusive license to develop bispecific and multispecific antibody products […]